General News

Recombinant Protein Market 2019 Global Industry Size, Share, Forecasts Analysis, Company Profiles, Competitive Landscape and Key Regions 2023 Available at Market Reports World

Recombinant Protein

360 Research Reports offers the latest published report on “Global Recombinant Protein Market – Segmented by Product (Hormone, Growth Factor, Cytokine, Antibody, Enzyme, and Other Products), Type of Application, and Geography – Growth, Trends, and Forecast (2019-2023)” delivering key insights and providing a competitive advantage to clients through a detailed report.

Global Recombinant Protein Market 2019-2023 considers the past, current and future state of the industry while encapsulating modest landscape analysis, manufacturers, marketing strategies, industry effect factor analysis. An unbiased and detailed analysis of the on-going trends, opportunities/ high growth areas has been included to help stakeholders to device and align Recombinant Protein market strategies according to the current and future market. All enterprise profiles of the main players and brands are shown in this research. The report presents the drivers and restrictions of the market that have been explained by SWOT analysis.

Recombinant Protein Market Segmentation by Major Players:

Abcam PLC, Abnova Corporation, Eli Lilly and Company, Enzo Life Sciences Inc., Eurogentec (Kaneka Corporation), Merck KGaA, Novo Nordisk AS, Novoprotein, Prospec-Tany Technogene Ltd, R&D Systems (Bio-Techne), Roche Diagnostics, and ThermoFisher Scientific

Get Sample Copy of this Report – https://www.360researchreports.com/enquiry/request-sample/13104495

Overview of Recombinant Protein Market Report:

The recombinant protein market is expected to register a growth rate of nearly 6.5% over the forecast period, 2019-2023. Recombinant proteins are encoded by recombinant DNA, which involves the insertion of DNA encoding that particular protein into bacterial or mammalian cells, and the protein is then purified after getting expressed in these cells. Recombinant protein is produced either by molecular cloning or through polymerase chain reaction (PCR). The prominence of recombinant proteins has been increasing tremendously for therapeutic application, owing to advancement in technologies, which further facilitates market growth by developing alternative expression technologies and enhanced cell culture systems. It is also considered to be the foundation of biomolecular research and the developing biotechnology industry. As per the geographical analysis, the North American region possesses several factors, such as well-developed research infrastructure and higher expenditure in biomedical research, which makes this market to retain dominance in this region.

Growing Prevalence of Chronic Diseases Boosts the Growth of the Recombinant Protein Market

The prevalence of chronic diseases, such as cancer, diabetes, and arthritis, are on the rise, globally, as well as the treatment of the aforementioned diseases. As per the statistics recorded by the World Health Organization (WHO), the number of people with diabetes increased to 422 million in 2014, and in 2015, approximately 1.6 million deaths were directly caused due to diabetes and its associated complications. This exponential rise presents an urgent need to establish an effective diabetes therapy, where recombinant insulin plays a major role. Arthritis is also one of the leading causes of disability among adults in the United States, where about 54 million adults have doctor-diagnosed arthritis. This huge burden of arthritis needs disease management through different recombinant proteins, thus, fueling the recombinant protein market.
Other factors contributing to the recombinant protein market are, the growing expenditure in the R&D sector, rising inclination toward biologics and biosimilars, and advanced recombinant products.

Expensive and Time-consuming Production Process Limits the Growth of the Recombinant Protein Market

Recombinant protein production is a very time-consuming procedure, which requires high maintenance. The cost of the recombinant protein produced in E. coli is around EUR 10,000–15,000/mg, this high cost thus indicates the need of alternate platform, which is expected to restrain the recombinant protein market.
Another factor limiting the growth of this market is the safety issues associated with recombinant proteins.

North America is Expected to Dominate the Recombinant Protein Market over the Forecast Period

North America is expected to lead the global recombinant protein market, owing to the increasing expenditure in research. The United States is anticipated to witness highest growth, owing to the largest concentration of world-class research universities and academic medical centers. The R&D spending of the United States is around 2.7% of its gross domestic products (GDP). In 2014, The United States was leading the R&D investments in biotechnology, and since then, the US biotechnology research and investment has been growing at a steady rate. Development of new products and collaboration activities of biotechnology companies are likely to boost the growth of the recombinant protein market.
Thus, the increasing expenditure and major focus on R&D are expected to generate high opportunities for the growth of the North American recombinant protein market.

Inquire more or share questions if any for this Report @ https://www.360researchreports.com/enquiry/pre-order-enquiry/13104495    

Reasons to Purchase this Report:

  • Current and future recombinant protein market outlook in the developed and emerging markets
  • Analysis of the various perspectives of the market with the help of Porter’s five forces analysis
  • The segment that is expected to dominate the market
  • Regions that are expected to witness the fastest growth during the forecast period
  • Identify the latest developments, market shares, and strategies employed by the major market players
  • 3-month analyst support, along with the Market Estimate sheet (in Excel)

    Order a copy of Recombinant Protein Market Report 2019 @ https://www.360researchreports.com/purchase/13104495

    Important factors that are mentioned in the Recombinant Protein Market report 2023…

    Key Market Dynamics:  The Global Recombinant Protein Market research report provides complete forecasts on the latest market trends, development methods, and research methodologies. Some of the factors that are directly in affecting the market including the Strategic Production and Methods, development platforms, and the product model itself, and even a minute change within the product profile would result in a huge amount of changes within the mentioned factors. All of these factors are explained in detail in the research study.

    Major Growth Prospects: The report also focuses on some of the Key growth prediction, including new product launches, Mergers and Acquisitions, Research and Development, joint ventures, collaborations, agreements, partnerships, and growth of the key Manufacturers working effectively in the market, both in terms of regional and global scale depending on geography.

    Key Market Highlights:  The report gives us an in-depth Market analysis on some of the Recombinant Protein Market key factors, including revenue, cost, capacity, capacity utilization rate, production, production rate, consumption, supply, demand, Market share, CAGR, and gross margin. Additionally, the report presents a comprehensive study of the market growth factors and their latest trends, along with related Market sections and subsections.

    Potential Customers: The Recombinant Protein Market report provides significant insights to readers, service providers, suppliers, distributors, manufacturers, stakeholders, and individuals who are interested in evaluation and self-studying the Recombinant Protein market.

     “We also can offer a customized report to fulfill the special requirements of our clients. Regional and Countries report can be provided as well.”